The Company reports revenues of $5.2M in Q4 and $18.1M for the year
KELOWNA, British Columbia and VANCOUVER, British Columbia, Nov. 28, 2019 /PRNewswire/ — Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE:SNN, OTCQB:SNNVF) and CannaPharmaRx Canada Corp. (“CannaPharmaRx”), a subsidiary of CannaPharmaRx, Inc. (OTC Pink: CPMD) today jointly announce that they are extending the outside date of the Share Purchase Agreement previously announced on June 11, 2019 with respect to the sale of the shares of Sunniva Medical Inc. (“SMI”) to CannaPharmaRx (the “SMI Transaction”) until December 20, 2019. The terms of the SMI Transaction, as amended on October 2, 2019, otherwise remain unchanged, with the purchase price to be satisfied by way of CAD $16.0 million in cash (less outstanding indebtedness of SMI at closing) and CAD $4.0 million by way of a promissory note of CannaPharmaRx (the “CPMD Note”). The Company and CannaPharmaRx continue to work as expeditiously as possible to complete the transaction on or prior to the amended outside date.
TORONTO, Nov. 28, 2019 /CNW/ – ALL TIMES ARE LOCAL
NEW YORK, Nov. 27, 2019 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of HEXO Corp., Inc. (“HEXO” or the “Company”) (NYSE: HEXO) between January 25, 2019 and November 15, 2019, (the “Class Period”). The lawsuit filed in the United States District Court for the Southern District of New York alleges violations of the Securities Exchange Act of 1934.
SMITHS FALLS, ON, Nov. 27, 2019 /PRNewswire/ – On November 28(th), 2019, Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) will officially unveil its new portfolio of Cannabis 2.0 products, including its Distilled Cannabis(TM) concept, chocolates, vape cartridges and vape pens at a media launch event in Toronto, Ontario.
/NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS./
CALGARY, Nov. 27, 2019 /CNW/ – YSS Corp.(TM) (the “Company” or “YSS”) (TSXV: YSS) (WKN: A2PMAX), a premier Canadian cannabis retailer with operations under the YSS(TM) and Sweet Tree(TM) brands and a trusted destination to explore and discover cannabis in Canada, is pleased to announce its third quarter 2019 financial results and provide a preliminary fourth quarter outlook. Selected financial and operational information is outlined below and should be read in conjunction with YSS’ condensed interim consolidated financial statements for the three and nine months ended September 30, 2019 and related management’s discussion and analysis (“MD&A”) which are available on SEDAR at www.sedar.com.
MINNEAPOLIS, Nov. 27, 2019 /PRNewswire/ — Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), a science-focused, multi-state cannabis company with operations in 10 states and the Commonwealth of Puerto Rico, today reported financial results for its third quarter ended September 30, 2019. All currency figures referenced in this release reflect U.S. dollar amounts.
Company represented at Bryan Garnier Cannabis Conference
11,000 Square Foot Retail Destination and Global Centre for Cannabis Education, Discovery and Community Engagement